• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单剂量的三种不同眼科用β受体阻滞剂可拮抗健康志愿者中异丙肾上腺素的变时性效应。

A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.

作者信息

Berlin I, Marcel P, Uzzan B, Millon D, Le Hoang P, Puech A J

出版信息

Clin Pharmacol Ther. 1987 Jun;41(6):622-6. doi: 10.1038/clpt.1987.85.

DOI:10.1038/clpt.1987.85
PMID:2884059
Abstract

The systemic effect of three beta-blocking eyedrops was compared in a placebo-controlled, double-blind trial in 12 healthy male volunteers. Each subject received successively each treatment in random order at weekly intervals. The eyedrops administered were as follows: 0.5% timolol, 2% carteolol, 0.6% metipranolol, and placebo. We evaluated the intraocular pressure and systemic beta-blockade 3 hours after a single administration of one eyedrop in each eye. The systemic beta-blocking effect was evaluated by the isoproterenol sensitivity test, that is the dose of isoproterenol required to increase resting heart rate by 25 bpm (I25). Each beta-blocking eyedrop antagonized the chronotropic effect of isoproterenol. I25 for placebo was 3.1 +/- 0.5 micrograms, for metipranolol 5.2 +/- 0.9 micrograms (P less than 0.005), for timolol 10.9 +/- 1.9 micrograms (P less than 0.001), and for carteolol 39.6 +/- 5.4 micrograms (P less than 0.0005). Each treatment significantly decreased the intraocular pressure: metipranolol 3.6 +/- 0.4 mm Hg (P less than 0.001), timolol 2.44 +/- 0.4 mm Hg (P less than 0.01), and carteolol 2.38 +/- 0.48 mm Hg (P less than 0.01) compared with placebo. The resting heart rate and blood pressure were not influenced by the treatments. Even though the results might be different in the case of an earlier or a later time of evaluation or chronic administration, we believe that the isoproterenol sensitivity test may be used to evaluate the systemic effect of beta-blocking eyedrops.

摘要

在一项针对12名健康男性志愿者的安慰剂对照双盲试验中,比较了三种β受体阻滞剂眼药水的全身效应。每个受试者每周按随机顺序依次接受每种治疗。所使用的眼药水如下:0.5%噻吗洛尔、2%卡替洛尔、0.6%美替洛尔和安慰剂。在每只眼睛单次滴入一种眼药水3小时后,我们评估了眼压和全身β受体阻滞情况。通过异丙肾上腺素敏感性试验评估全身β受体阻滞效应,即使静息心率增加25次/分钟(I25)所需的异丙肾上腺素剂量。每种β受体阻滞剂眼药水都拮抗了异丙肾上腺素的变时效应。安慰剂的I25为3.1±0.5微克,美替洛尔为5.2±0.9微克(P<0.005),噻吗洛尔为10.9±1.9微克(P<0.001),卡替洛尔为39.6±5.4微克(P<0.0005)。每种治疗均显著降低了眼压:与安慰剂相比,美替洛尔降低了3.6±0.4毫米汞柱(P<0.001),噻吗洛尔降低了2.44±0.4毫米汞柱(P<0.01),卡替洛尔降低了2.38±0.48毫米汞柱(P<0.01)。静息心率和血压不受这些治疗的影响。尽管在更早或更晚的评估时间或长期给药的情况下结果可能不同,但我们认为异丙肾上腺素敏感性试验可用于评估β受体阻滞剂眼药水的全身效应。

相似文献

1
A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.单剂量的三种不同眼科用β受体阻滞剂可拮抗健康志愿者中异丙肾上腺素的变时性效应。
Clin Pharmacol Ther. 1987 Jun;41(6):622-6. doi: 10.1038/clpt.1987.85.
2
[Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].[β受体阻滞剂滴眼液对健康志愿者全身β肾上腺素能受体阻滞作用的比较]
Ann Fr Anesth Reanim. 1989;8(1):46-50. doi: 10.1016/s0750-7658(89)80142-x.
3
Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.三种β受体阻滞剂滴眼液的全身效应:健康志愿者中β1和β2肾上腺素能受体抑制作用的比较
Clin Pharmacol Ther. 1990 May;47(5):578-83. doi: 10.1038/clpt.1990.78.
4
Assessment of systemic effects of different ophthalmic beta-blockers in healthy volunteers.健康志愿者中不同眼科β受体阻滞剂全身效应的评估。
Clin Pharmacol Ther. 1991 Jun;49(6):658-64. doi: 10.1038/clpt.1991.83.
5
Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.健康志愿者对美替洛尔和噻吗洛尔滴眼液的心血管反应。
Br J Clin Pharmacol. 1989 Jan;27(1):1-5. doi: 10.1111/j.1365-2125.1989.tb05327.x.
6
[Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].[哮喘与β受体阻滞剂眼药水(噻吗洛尔、美替洛尔、卡替洛尔)。对异丙肾上腺素变时作用的抑制]
Allerg Immunol (Paris). 1988 Sep;20(7):267-9.
7
[Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].[卡替洛尔和美替洛尔滴眼液对哮喘患者通气和心血管功能影响的比较]
J Fr Ophtalmol. 1987;10(8-9):485-90.
8
[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].[在正常情况下,768例患者中卡替洛尔滴眼液与其他β受体阻滞剂的多中心比较研究]
Klin Monbl Augenheilkd. 1988 Feb;192(2):167-72. doi: 10.1055/s-2008-1050097.
9
Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.健康志愿者对局部应用2%卡替洛尔和0.5%噻吗洛尔的眼部及心血管反应。
Br J Ophthalmol. 1988 Feb;72(2):101-3. doi: 10.1136/bjo.72.2.101.
10
Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.β-肾上腺素能受体阻滞剂对眼血流的短期影响。
Curr Eye Res. 2001 Oct;23(4):298-306. doi: 10.1076/ceyr.23.4.298.5448.

引用本文的文献

1
Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.噻吗洛尔滴眼液:用于青光眼和高眼压症治疗的综述
Drugs Aging. 2007;24(6):509-28. doi: 10.2165/00002512-200724060-00007.
2
Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.健康志愿者中含与不含苯扎氯铵的2%卡替洛尔局部用药的短期对比研究。
Br J Ophthalmol. 1998 Jan;82(1):39-42. doi: 10.1136/bjo.82.1.39.
3
Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.
眼部用美替洛尔。其药效学和药代动力学特性以及在青光眼和高眼压症治疗效果的初步综述。
Drugs. 1988 Nov;36(5):601-15. doi: 10.2165/00003495-198836050-00004.
4
Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.噻吗洛尔滴眼液。其药理特性及在青光眼和高眼压症治疗中的应用综述。
Drugs Aging. 1992 Jan-Feb;2(1):58-77. doi: 10.2165/00002512-199202010-00007.
5
Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects.对哮喘患者局部应用丁胺基苯氧基丙醇乙酸酯(一种眼选择性β-肾上腺素能受体阻滞剂)后支气管效应的评估。
Br J Clin Pharmacol. 1992 Aug;34(2):122-9. doi: 10.1111/j.1365-2125.1992.tb04120.x.
6
Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.青光眼治疗中的眼部β受体阻滞剂。临床药理学方面。
Drugs Aging. 1992 May-Jun;2(3):208-21. doi: 10.2165/00002512-199202030-00005.